Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 7,140 | 6,743 | 3,905 | 2,902 | 0 |
| Operating Income | -7,140 | -6,743 | -3,905 | -2,902 | N/A |
| Other Income | 18 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -7,122 | -6,743 | -3,905 | -2,902 | 0 |
| Net Income Continuous | -7,122 | -6,743 | -3,905 | -2,902 | N/A |
| Net Income | $-7,122 | $-6,743 | $-3,905 | $-2,902 | $N/A |
| EPS Basic Total Ops | 26.30 | -0.68 | -14.46 | -14.22 | N/A |
| EPS Basic Continuous Ops | 26.19 | -0.68 | -14.41 | -14.16 | N/A |
| EPS Diluted Total Ops | 26.30 | -0.68 | -14.46 | -14.22 | N/A |
| EPS Diluted Continuous Ops | 26.19 | -0.68 | -14.41 | -14.16 | N/A |
| EBITDA(a) | $-7,111 | $-6,743 | $-3,905 | $-2,902 | $N/A |